The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM)?
Nancy E. Kemeny
Research Funding - Pfizer; Sanofi
Yuman Fong
Honoraria - Genentech
Philip Paty
No relevant relationships to disclose
Joanne F. Chou
No relevant relationships to disclose
Marinela Capanu
No relevant relationships to disclose
Alexandra N. Gewirtz
No relevant relationships to disclose
William R. Jarnagin
No relevant relationships to disclose
Ronald P. DeMatteo
No relevant relationships to disclose
Peter J Allen
No relevant relationships to disclose
T. Peter Kingham
No relevant relationships to disclose
Celina Ang
No relevant relationships to disclose
Andrea Cercek
No relevant relationships to disclose
Michael Ian D'Angelica
No relevant relationships to disclose